Hypothesis

3 Matching Annotations

Last 7 days
www.sciencedirect.com www.sciencedirect.com

Neoadjuvant Fc-enhanced anti-CTLA-4 targets Tregs to augment androgen deprivation in high-risk prostate cancer: A randomized phase I trial

1
1. scibot 27 Feb 2026
  
  in Public
  
  RRID:AB_11147759
  
  DOI: 10.1016/j.xcrm.2026.102638
  
  Resource: (BioLegend Cat# 104731, RRID:AB_11147759)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_11147759
  
  What is this?
  
  RRID:AB_11147759
Visit annotations in context

Tags

RRID:AB_11147759

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379126000558
Jan 2020
www.sciencedirect.com www.sciencedirect.com

Untitled document

1
1. scibot 13 Jan 2020
  
  in Public
  
  RRID:AB_11147759
  
  DOI: 10.1016/j.celrep.2019.01.025
  
  Resource: (BioLegend Cat# 104731, RRID:AB_11147759)
  
  Curator: @ethanbadger
  
  SciCrunch record: RRID:AB_11147759
  
  What is this?
  
  RRID:AB_11147759 RRIDCUR:Validated
Visit annotations in context

Tags

RRIDCUR:Validated

RRID:AB_11147759

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2211124719300348
Nov 2017
www.sciencedirect.com www.sciencedirect.com

Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade

1
1. scibot 08 Nov 2017
  
  in Public
  
  104731
  
  Curator: @bandrow
  
  Curator note: BioLegend Cat# 104731, RRID:AB_11147759
  
  Resource used:
  
  (BioLegend Cat# 104731, RRID:AB_11147759)
  
  SciCrunch record: RRID:AB_11147759
  
  Alternate resolvers: SciCrunch xml N2T identifiers.org
  
  What is this?
  
  RRID:AB_11147759
Visit annotations in context

Tags

RRID:AB_11147759

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S009286741631594X